ROCALTROL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Italy, Japan, Malta, Mexico, Netherlands, Singapore, Spain, UK.

Active ingredients

The drug ROCALTROL contains one active pharmaceutical ingredient (API):

1
UNII FXC9231JVH - CALCITRIOL
 

Calcitriol is the most active known form of vitamin D3 in stimulating intestinal calcium transport. In physiological amounts it augments the intestinal absorption of calcium and phosphate and plays a significant part in the regulation of bone mineralisation.

 
Read more about Calcitriol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ROCALTROL Soft capsules MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A11CC04 Calcitriol A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two → A11CC Vitamin D and analogues
Discover more medicines within A11CC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 2502Q
BR Câmara de Regulação do Mercado de Medicamentos 503421040023317
CA Health Products and Food Branch 00481815, 00481823
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00427968, 00427997, 00499778, 00499790, 01415973, 01416004, 02259914, 02259966, 02417572, 02417603, 03996299, 03996307, 04796898, 04796929, 04964166, 04964172, 04964195, 07379853, 07379876, 07379882, 07379899, 07463298, 07463306, 07487695, 07487703, 09916568, 10990009, 11557728, 11709629, 13781832, 15255591, 15266241, 15568404, 16910230, 16910247, 17448259
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 23.180-1-04-07
EE Ravimiamet 1004599, 1675931
ES Centro de información online de medicamentos de la AEMPS 55973, 55974
FR Base de données publique des médicaments 61847953
GB Medicines & Healthcare Products Regulatory Agency 22110, 29758
HK Department of Health Drug Office 05357, 05358
HR Agencija za lijekove i medicinske proizvode HR-H-153851334, HR-H-630148256
IT Agenzia del Farmaco 024280012, 024280024
JP 医薬品医療機器総合機構 3112004M1023, 3112004M2020, 3112402A1020, 3112402A2027
MT Medicines Authority AA565/48301, AA729/01902
MX Comisión Federal para la Protección contra Riesgos Sanitarios 341M80
NL Z-Index G-Standaard, PRK 16608, 16616
SG Health Sciences Authority 03865P
US FDA, National Drug Code 30698-143, 30698-144, 30698-911

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.